Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia

AF Srinivasan, L Rice, JR Bartholomew… - Archives of Internal …, 2004 - jamanetwork.com
Background Heparin-induced thrombocytopenia (HIT) is a common, often catastrophic,
syndrome that produces the most hypercoagulable of states. Emerging therapeutic strategies use …

Standard of care for lipedema in the United States

…, MS Schwartz, SM Dean, JR Bartholomew… - …, 2021 - journals.sagepub.com
Background Lipedema is a loose connective tissue disease predominantly in women
identified by increased nodular and fibrotic adipose tissue on the buttocks, hips and limbs that …

Impact of multidisciplinary pulmonary embolism response team availability on management and outcomes

…, GA Heresi, MZ Tong, JR Bartholomew - The American journal of …, 2019 - Elsevier
Treatment strategies for complex patients with pulmonary embolism (PE) are often debated
given patient heterogeneity, multitude of available treatment modalities, and lack of …

A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery

…, C Bajzer, HL Gornik, BH Gray, JR Bartholomew… - Journal of the American …, 2013 - jacc.org
Objectives : The aim of this study was a comparison of risk-adjusted outcomes of 3 approaches
to carotid revascularization in the open heart surgery (OHS) population. Background : …

Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population

YP Liew, JR Bartholomew, S Demirjian… - Clinical Journal of the …, 2008 - journals.lww.com
Background and objectives: Chronic kidney disease (estimated glomerular filtration rate<
60 ml/min per 1.73 m 2) and peripheral arterial disease (ankle-brachial index< 0.9) …

Pathophysiology of peripheral arterial disease and risk factors for its development.

JR Bartholomew, JW Olin - Cleveland Clinic journal of medicine, 2006 - europepmc.org
Peripheral arterial disease (PAD) is a systemic atherosclerotic process for which the major
risk factors are similar to those for atherosclerosis in the carotid, coronary, and other vascular …

Safety and efficacy of thrombolytic therapy for superior vena cava syndrome

…, JW Olin, RA Graor, JR Young, JR Bartholomew… - Chest, 1991 - Elsevier
The experience at the Cleveland Clinic from 1982 to 1990 using thrombolytic therapy for
superior vena cava (SVC) syndrome was retrospectively reviewed. Sixteen patients, 11 of …

Smokeless tobacco and cardiovascular risk

R Gupta, H Gurm, JR Bartholomew - Archives of internal …, 2004 - jamanetwork.com
This article discusses the evolution of smokeless tobacco in the United States and interprets
the available data on cardiovascular risk factors and cardiovascular mortality associated …

Control of bleeding in patients with immune and nonimmune thrombocytopenia with aminocaproic acid

JR Bartholomew, R Salgia… - Archives of internal …, 1989 - jamanetwork.com
• Patients with thrombocytopenia have an increased risk of bleeding. We have used 18 courses
of aminocaproic acid in 17 patients with either immune or nonimmune thrombocytopenia …

Update on the management of venous thromboembolism.

JR Bartholomew - Cleveland Clinic journal of medicine, 2017 - europepmc.org
Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary
embolism, is a common cardiovascular disease associated with significant morbidity …